investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Does the RNA editor Apobec-1 shift microRNA targeting to a tumorigenic effect?

Dewi Harjanto

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Dewi Harjanto

Rockefeller University

New York, United States

Related projects

Steven Mark Larson

MSKCC Center for Molecular Imaging in Cancer

Melanoma of skin All cancers but non-melanoma skin cancer

Donald Court

Lambda Genetic Networks and Lambda Red-Mediated Recombination

All cancers but non-melanoma skin cancer

Alfred Singer

MHC-independent T cells

All cancers but non-melanoma skin cancer

Gary M Wessel

Post-translational Regulation of Germline Determinants

Melanoma of skin All cancers but non-melanoma skin cancer

Carol Thiele

Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma

All cancers but non-melanoma skin cancer

Ian Lisle Linde

Mechanistic basis of allogeneic IgG-induced tumor eradication

Melanoma of skin

Caryn Lerman

Pharmacogenetics of Nicotine Addiction Treatment

All cancers but non-melanoma skin cancer

Komaraiah Palle

Ras18-mediated Fanconi Anemia pathway activation in response to camptothecin

All cancers but non-melanoma skin cancer Melanoma of skin

Jerry Pelletier

Targeting the DHX9 Helicase for Small Molecule Probe Discovery

All cancers but non-melanoma skin cancer